Net profit "Pharmsintez" under RAS for 3 months. 2020 amounted to ₽124,048 million, having increased by 16,5 times in comparison with ₽7,497 million in the previous year. Revenue decreased by 2 times to ₽28,419 mln. as compared to ₽59,523 mln. a year earlier.